MDS Strategic Plan (2014-2017)

The International Parkinson and Movement Disorder Society

The objective and mission of the Society shall be to advance the neurological sciences pertaining to Movement Disorders to improve the diagnosis and treatment of patients; to operate exclusively for scientific, scholarly and educational purposes; to encourage research; to provide forums, such as medical journals, scientific symposia and International Congresses, for sharing ideas and for advancing the related clinical and scientific disciplines; and to encourage interest and participation in the activities of the Society among healthcare professionals and scientists; and to collaborate with other related professional and lay organizations.

Mission and Goals
The International Parkinson and Movement Disorder Society is a professional society of clinicians, scientists, and other healthcare professionals who are interested in Parkinson's disease, related neurodegenerative and neurodevelopmental disorders, hyperkinetic Movement Disorders and abnormalities in muscle tone and motor control.

  1. To disseminate knowledge about Movement Disorders by:
    1. Providing educational programs for clinicians, scientists and the general public designed to advance scientific and clinical knowledge about Movement Disorders
    2. Sponsoring International Congresses and Symposia on Movement Disorders
    3. Collaborating with other international organizations and lay groups
    4. Publishing journals, videotapes and other collateral materials committed to high scientific standards and peer review
  2. To promote research into causes, prevention and treatment of Movement Disorders by:
    1. Using the Society's influence and resources to enhance support for research
    2. Facilitating the dissemination of information about research
    3. Encouraging the training of basic and clinical scientists in Movement Disorders and related disorders
  3. For the purposes of favorably affecting  the care of patients with Movement Disorders, the Society will provide expertise, advice  and guidance to:
    1. Regulatory agencies to assist them in the approval process of safe and effective therapeutic interventions
    2. The public (media) and patient support groups by informing them of new research and therapeutic advances
    3. Governments to assist them in the development of policies that affect support of research and patient care
    4. Educational efforts to assist in developing standards of training in the specialty

2014-2017 Strategic Plan

A. Develop and deliver innovative education that reflects the broad and evolving needs of Movement Disorder specialists, general neurologists, primary care physicians and other health professionals 1. Increase the breadth and depth of educational programs including online learning, enduring material, non English translations of educational material (e.g. Basic Movement Disorder Course and Coffee Break CME) based on the results of the needs assessment survey LT
2. Ask the regional Sections to focus their developing world educational efforts in the most under-served areas in their regions, likely creating educational programs for non physician health professionals MT
3. Determine if future courses on the following are warranted: MT
i) teaching courses for basic scientists
ii) educational programs for industry representatives
iii) the use of telemedicine in educating in resource-poor countries
4. Implement a learning management system to provide consistency and data collection opportunities for MDS’s online learning activities ST
5. Create a self-assessment exam that meets the criteria for Maintenance of Certification in the USA MT
B. Develop educational resources for patient organizations and for members to distribute to patients 1. Develop a slide set on the highlights of the Congress within a very short period after the Congress and make available to patient organizations.  ST
2. Develop disease state fact sheets that members can provide to their patients LT
3. Establish a patient meeting in conjunction with the Congress in collaboration with local patient groups  ST
C.  Promote and maintain the Congress as the premier educational event for Movement Disorder specialists 1. Increase attendance by 10% by 2017.  LT
2. Continue to engage the highest level experts as Congress speakers,  ensuring geographic diversity  ST
3. Provide educational programs at the basic and advanced levels during the Congress ST
4. Ask the CSPC to appoint a sub committee to draft recommendations for the Officers consideration regarding Congress format enhancements MT
D. In concert with the Development Committee, identify new revenue streams to support the Society’s educational activities and other initiatives that address the needs of members and the Movement Disorders community 1. Explore the feasibility of establishing a Corporate Roundtable MT
2. Provide industry with an opportunity to host scientific exhibits/innovation suites during the MDS Congress  ST
3. Establish a travel grant program for Congress to take the place of industry supported travel MT
A. Increase membership in Europe and North America
1. Explore MDS-ES and EAN joint membership opportunity MT
2. Consider featuring new members on the website ST
3. Consider an Associate Member category ST
B. Increase membership from underrepresented regions 1. Task the Committee on Membership and the MDS Sections to develop plans to increase the outreach to segments of the membership that are underrepresented  MT
i) PAS to focus on Latin America
ii) ES to consider opportunities in Africa
iii) AOS to focus on China, India, Middle and Far East
C. Increase member awareness and perceived value of MDS programs and initiatives 1. Enhance Society exhibit booth ST
2. Create branded items with Society name and logo MT
3. Create a Web tour for new members MT
4. Promote MDS programs on the slides that are shown in between sessions at the Congress ST
5. Create Congress bag inserts promoting the Society ST
A.  Increase the quality and impact of the journal, ranking it 20th out of the Clinical Neurology titles per the ISI by 2017 1. Ask the journal editors to focus their efforts on raising the journal impact factor LT
2. Explore the feasibility of non English translations of the journal LT
B. Monitor and proactively anticipate future technological and policy developments in the publishing arena 1. MDS Officers will establish a closer working relationship with the Society’s publisher and with monitoring policy developments in the publishing arena ST
2. Establish yearly meetings with the publisher, Web editors, journal editors and Officers ST
C. Create a clinical practice online journal 1. Discuss the second journal with Wiley Blackwell ST
2. Explore other publishing options, including self-publication ST
D. Improve the MDS Website and social media presence with expanded resources to enhance outreach for the organization 1. Evaluate and support membership interest in communications medium, electronic information, and utilization of technology and social media
2. Task the Publications Oversight Committee to develop a plan to ensure the successful transition of the Website to new Editors LT
3. Consider a new Website platform that would allow members to access material from a mobile device, tablet or desktop, would allow better viewing of multimedia content and would improve search capabilities MT
A. Foster and uphold the integrity of MDS leaders and members with regard to Conflict of Interest 1. Implement a “Code of Conduct” or “MDS Code for Interaction with Companies” ST
2. Establish a Conflict of Interest Review Committee ST
3. Regularly review and update the policy on conflict of interest LT
B. Strengthen the Society’s regional Sections 1. Establish an annual meeting of the regional leadership to discuss issues of mutual interest ST
2. Establish uniform governance across regional Sections ST
3. Establish uniform financial policies that ensure central management of funds ST
4. Foster exchange between higher education programs within the regions MT
C. Create an income generating program from rating scales, including scale licensing, certification and translation 1. Develop an overarching business plan for the marketing of scales related to movement disorders including the following elements:
  1. Develop a procedure to acquire scales of interest which will serve the needs for high quality clinical studies LT
  2. Further develop an official MDS Scale Program that should involve
    1. a specific training on a given scale available to physicians and sponsors.
    2. advice for sponsors on concepts of measurement, clinimetrics and application of our scales. MT
  3. Formalize a policy to engage members as scientific advisors and trainers ST
  4. Conduct an outside review of the rating scale program and seek recommendations on how best to structure the activities to ensure that the program meets industry standards and expectations. ST
A. Promote research into causes, prevention and treatment of Movement Disorders 1. Endorse and facilitate the creation of study groups in areas where clinical studies for diagnosis and/or treatment or collaborative basic science research is needed ST
2. Consider highlighting MDS-endorsed study group research at the Congress ST
3. Improve study groups’ ability to raise research funding LT
4. Develop a supported meeting program for Study Groups LT
5. Facilitate meetings of the Study Groups during the MDS Congresses ST
6. Develop programs that increase the bi-directional exchange between clinicians and basic scientists LT
B. Further evidence-based reviews for best Movement Disorders practice 1. Charge the Scientific Issues Committee with addressing relevant ethical, clinical and scientific issues related to Movement Disorders.LT
C. Increase awareness of the Society and Movement Disorders subspecialty among the public and other related societies 1. Initiate a bylaws referendum to include "Parkinson" in the Society’s name ST
2 Make a Congress slide set available for the affiliated National Societies to organize local meetings highlighting the MDS Congress with this material. ST
3. Distribute press releases on salient articles published in Movement DisordersInclude patient organizations and national/regional affiliate organizations on the distribution list.ST
4. Develop MDS branded material (logo pins, ties, scarves, etc.) MT
D. Develop and utilize mutual relationships to enhance the MDS mission, goals and objectives 1. Identify, define and prioritize strategic relationships with other medical organizations LT
2. Define the role of liaisons to improve the interface with organizations with shared interests LT

ST=Short-Term (6-12 months) MT=Medium-Term (1-2 years) LT=Long-Term (3-4 years; ongoing)